Genome-wide association studies in lung disease
- Departments of Health Sciences and Genetics, University of Leicester, University Road, Leicester, UK
- Correspondence to María Soler Artigas, 2nd Floor, Adrian Building, University of Leicester, Leicester LE1 7RH, UK; msa20{at}le.ac.uk
-
Contributors The literature review and drafting of the manuscript was wholly undertaken by the named authors.
- Received 1 July 2011
- Accepted 18 July 2011
- Published Online First 19 August 2011
Abstract
Genome-wide association studies (GWAS) have provided new insights into the molecular mechanisms of lung function and lung diseases. GWAS, and studies that build upon their findings, will continue to provide evidence aimed at advancing understanding of lung disease. This paper summarises the key features of a GWAS, references some recent findings and discusses how the chest physician can interpret the validity and utility of future GWAS and related studies.
- Asthma genetics
- respiratory measurement
- COPD epidemiology
- clinical epidemiology
- COPD mechanisms
- asthma
- asthma mechanisms
- COPD exacerbations
- cough/mechanisms/pharmacology
- asthma guidelines
- cystic fibrosis
- exhaled airway markers
- lung physiology
- paediatric asthma
- paediatric lung disaese
- airway epithelium
- allergic lung disease
- cytokine biology
- eosinophil biology
- innate immunity
- lymphocyte biology
- airway epithelium
- allergic lung disease
- eosinophil biology
- asthma genetics
- respiratory measurement
Footnotes
-
Funding This work was supported by the Medical Research Council (G0902313).
-
Competing interests None.
-
Provenance and peer review Commissioned; internally peer reviewed.









